Nu Skin Enterprises, Inc. (NUS) Earnings History
Net Loss31 years of earnings data (1995–2025) · Currently unprofitable on a TTM basis
Loading earnings history...
Nu Skin Enterprises, Inc. (NUS) Earnings Overview
As of November 8, 2026, Nu Skin Enterprises, Inc. (NUS) reported trailing twelve-month net income of -$234M, reflecting +207.8% year-over-year growth. The company earned $-4.81 per diluted share over the past four quarters, with a net profit margin of 10.8%.
Looking at the long-term picture, NUS's 5-year EPS compound annual growth rate (CAGR) stands at -2.6%, signaling declining earnings. The company achieved its highest annual net income of $365M in fiscal 2013.
Nu Skin Enterprises, Inc. is currently reporting a net loss, though operating performance should be evaluated in the context of growth investments and industry dynamics View revenue history →
Compared to peers including HLF ($178M net income, 4.5% margin), USNA (-$21M net income, 1.2% margin), NATR ($15M net income, 4.1% margin), NUS has outperformed on profitability metrics. Compare NUS vs HLF →
NUS Earnings vs Peers
Earnings metrics vs comparable public companies
NUS Historical Earnings Data (1995–2025)
31 years| Fiscal Year | Net Income | YoY % | Operating Income | EPS (Diluted) | Net Margin | Op. Margin |
|---|---|---|---|---|---|---|
| 2025 | $160M | +209.3% | $91M | $3.18 | 10.8% | 6.1% |
| 2024 | -$147M | -1805.6% | -$152M | $-2.95 | -8.5% | -8.8% |
| 2023 | $9M | -91.8% | $48M | $0.17 | 0.4% | 2.5% |
| 2022 | $105M | -28.9% | $111M | $2.07 | 4.7% | 5.0% |
| 2021 | $147M | -23.0% | $234M | $2.86 | 5.5% | 8.7% |
| 2020 | $191M | +10.3% | $258M | $3.63 | 7.4% | 10.0% |
| 2019 | $174M | +42.4% | $267M | $3.10 | 7.2% | 11.0% |
| 2018 | $122M | -5.8% | $241M | $2.16 | 4.5% | 9.0% |
| 2017 | $129M | -9.5% | $274M | $2.36 | 5.7% | 12.0% |
| 2016 | $143M | +7.5% | $231M | $2.55 | 6.5% | 10.5% |
| 2015 | $133M | -29.7% | $245M | $2.25 | 5.9% | 10.9% |
| 2014 | $189M | -48.2% | $352M | $3.11 | 7.4% | 13.7% |
| 2013 | $365M | +64.6% | $554M | $5.94 | 11.5% | 17.4% |
| 2012 | $222M | +44.6% | $341M | $3.52 | 10.2% | 15.7% |
| 2011 | $153M | +12.7% | $234M | $2.38 | 8.8% | 13.4% |
| 2010 | $136M | +51.4% | $217M | $2.11 | 8.9% | 14.1% |
| 2009 | $90M | +37.5% | $148M | $1.40 | 6.7% | 11.1% |
| 2008 | $65M | +48.9% | $125M | $1.02 | 5.2% | 10.1% |
| 2007 | $44M | +33.7% | $71M | $0.67 | 3.8% | 6.1% |
| 2006 | $33M | -55.7% | $55M | $0.47 | 2.9% | 4.9% |
| 2005 | $74M | -4.7% | $123M | $1.04 | 6.3% | 10.4% |
| 2004 | $78M | +14.4% | $126M | $1.07 | 6.8% | 11.1% |
| 2003 | $68M | +4.7% | $107M | $0.85 | 6.9% | 10.9% |
| 2002 | $65M | +28.9% | $106M | $0.78 | 6.7% | 11.0% |
| 2001 | $50M | -18.5% | $71M | $0.60 | 5.7% | 8.1% |
| 2000 | $62M | -28.8% | $90M | $0.72 | 7.0% | 10.3% |
| 1999 | $87M | -16.6% | $130M | $0.99 | 9.7% | 14.5% |
| 1998 | $104M | +11.0% | $170M | $1.19 | 11.4% | 18.6% |
| 1997 | $94M | +14.6% | $139M | $1.36 | 10.5% | 15.6% |
| 1996 | $82M | +103.2% | $128M | $1.02 | 12.0% | 18.9% |
| 1995 | $40M | - | $59M | $0.50 | 11.2% | 16.4% |
Download Data
Export NUS earnings history in CSV or JSON format
Free sign-in required to download data
NUS Chart Terminal
Live VCP patterns, Cup & Handle overlays, support/resistance, and AI trade plans.
Live Breakouts Feed
High-probability breakout stocks crossing their pivot across 5 pattern engines.
Intrinsic Valuation
DCF models, multiple analysis, and analyst estimates.
Historical Returns
31+ years return with dividends reinvested.
Peer Comparison
Compare growth, multiples, and margins vs sector.
NUS — Frequently Asked Questions
Quick answers to the most common questions about buying NUS stock.
What is NUS earnings per share (EPS)?
NUS trailing twelve-month (TTM) diluted EPS is $-4.81, reflecting +207.8% year-over-year growth. The 5-year EPS CAGR is -2.6%. Complete EPS history from 1995 to 2025 is available in the table on this page.
What is Nu Skin Enterprises, Inc.'s net income?
Nu Skin Enterprises, Inc. (NUS) trailing twelve-month net income is $-234M as of 2025. Earnings grew +207.8% year-over-year.
Is NUS profitable?
NUS is not currently profitable on a TTM basis, reporting a net loss of $-234M. Net margin is +10.8%. Investors should monitor for a return to profitability.
What is NUS's earnings growth rate?
NUS compound annual EPS growth rates (CAGR): 1-Year: N/A, 3-Year: +15.4%, 5-Year: -2.6%, 10-Year: +3.5%. These figures measure the annualised rate of diluted EPS growth over each period, based on data from 1995 to 2025.
What are NUS's profit margins?
Nu Skin Enterprises, Inc. net profit margin is +10.8%, operating margin is +6.1%, and gross margin is +69.4%. Margins are within a typical range for the sector. Return on Equity is +22.0%.
Is NUS growing earnings?
Yes, NUS earnings are accelerating — EPS growth of +207.8% exceeds the 5-year CAGR of -2.6%. TTM net income reached $-234M. Earnings momentum is strengthening.
What was NUS's best earnings year?
Nu Skin Enterprises, Inc.'s highest annual net income on record is $365M, achieved in fiscal year 2013. Earnings history on this page spans 1995 to 2025 and includes all annual and quarterly figures.
What were NUS's earnings last quarter?
NUS's most recent reported quarter was Q3 2026. Net income was $-742000.00 with diluted EPS of $-0.02. For a full breakdown of all quarters, see the quarterly earnings table on this page.